Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03640507Phase 3Completed
Phase 3, randomised trial of chlorhexidine + alcohol in surgical site infection (SSI) and Infection (3 arms), sponsored by Columbia University. Primary endpoints: Post-intervention Aerobic Bacterial Colony Counts at 7 days and Post-intervention Anaerobic Bacterial Colony Counts at 7 days. Started Oct 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03640507.